FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/16/2022
Back to search
Official data from USPTO
XPHELYUM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Quick snapshot
ST13
US500000079302219Class
5, 9, 10, 42, 44
Filing
79302219
Registration
6648819
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
08/16/2022
Classification
Registered
Trademark type
Combined
Nice classes
5, 9, 10, 42, 44
Filing date
11/13/2020
Registration date
02/22/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/22/2022
Last transaction
02/22/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
FR
Examiner
CLARK, ANDREW
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
XPHELYUM
Representatives
James R Menker Holley & Menker, PA
Technical classification
Nice Classes
Class 5Class 9Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biological preparations for medical use for the treatment of conditionsailmentsdiseases and disorders of the electrical nervous system; Biological preparations for medical use for the treatment of inflammatory conditionsautoimmune diseasesinflammatory bowel diseasearthritismigrainesmetabolic disordersobesitydiabetesparalysissensory disorders and impairmentshypertensioncancercardiac rhythm managementsleep apneaParkinson diseaseAlzheimer's diseasedystonianeurodegenerative diseasesobsessive compulsive disorderdepressive disordersarrhythmiasepilepsyincontinence and chronic pain; biological preparations for veterinary use for the treatment of conditionsailmentsdiseases and disorders of the electrical nervous system; chemical preparations for medical use for the treatment of conditionsailmentsdiseases and disorders of the electrical nervous system; chemical preparations for medical use for the treatment of inflammatory conditionsautoimmune diseasesinflammatory bowel diseasearthritismigrainesmetabolic disordersobesitydiabetesparalysissensory disorders and impairmentshypertensioncancercardiac rhythm managementsleep apneaParkinson diseaseAlzheimer's diseasedystonianeurodegenerative diseasesobsessive compulsive disorderdepressive disordersarrhythmiasepilepsyincontinence and chronic pain; biological preparations for veterinary use for the treatment of conditionsailmentsdiseases and disorders of the electrical nervous system; chemical preparations for pharmaceutical usenamely for the treatment of conditionsailmentsdiseases and disorders of the electrical nervous system; chemical preparations for veterinary usefor the treatment of conditionsailmentsdiseases and disorders of the electrical nervous system; chemical reagents for medical or veterinary use; chemical-pharmaceutical preparations for the treatment of conditionsailmentsdiseases and disorders of the electrical nervous system; drugs for medical use for the treatment of conditionsailmentsdiseases and disorders of the electrical nervous system; drugs for medical use for the treatment of inflammatory conditionsautoimmune diseasesinflammatory bowel diseasearthritismigrainesmetabolic disordersobesitydiabetesparalysissensory disorders and impairmentshypertensioncancercardiac rhythm managementsleep apneaParkinson diseaseAlzheimer's diseasedystonianeurodegenerative diseasesobsessive compulsive disorderdepressive disordersarrhythmiasepilepsyincontinence and chronic pain; medicines for human medicine for the treatment of conditionsailmentsdiseases and disorders of the electrical nervous system; pharmaceutical preparations for the treatment of conditionsailmentsdiseases and disorders of the electrical nervous system; pharmaceutical products for the treatment of conditionsailmentsdiseases and disorders of the electrical nervous system; pharmaceutical preparations and pharmaceutical products for the treatment of inflammatory conditionsautoimmune diseasesinflammatory bowel diseasearthritismigrainesmetabolic disordersobesitydiabetesparalysissensory disorders and impairmentshypertensioncancercardiac rhythm managementsleep apneaParkinson diseaseAlzheimer's diseasedystonianeurodegenerative diseasesobsessive compulsive disorderdepressive disordersarrhythmiasepilepsyincontinence and chronic pain
Class 9
Electric apparatus for switchingelectric switches; data processing apparatus; intercommunication apparatustelephones incorporating intercommunication systems; measuring apparatusanalyzers for measuringtesting and analyzing blood and other bodily fluids and temperature sensors used in the medical field to measure temperature of medical solutionstesting and analyzing heartbeatsensors measuring body functions; monitoring apparatusother than for medical useelectronic monitors and monitor modules for monitoring electric current and electrical signals; apparatus and instruments for physicselectrodessensors collecting physical signals; precision measuring apparatuslasers for measuring; remote control apparatusremote control transmitter for radio-controlled devices; chips being integrated circuits; integrated circuits; interfaces for computers; microprocessors; Processors being central processing unitscentral processing units for processing informationdatasoundspeech or images; telecommunications transmitters; smart rings; telecommunication apparatus in the form of jewelrysmart rings; Wearable computers in the nature of smart glasses and smart watches
Class 10
Medical apparatus and instruments for stimulating the nervous system; veterinary apparatus and instruments for stimulating the nervous system
Class 42
Industrial research in biology; industrial research in chemistry; conducting clinical trials for others; medical research; scientific research; industrial research relating to technology; industrial research in the field of physics; industrial research in the field of telecommunication technology
Class 44
Health care services; telemedicine services; therapy servicesphysical therapy and mental health therapy services
Publications
History of USPTO decisions and trademark events.
24 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/27/2022
FIMP
FINAL DISPOSITION PROCESSED
07/27/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/22/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
02/22/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/07/2021
PUBO
PUBLISHED FOR OPPOSITION
12/07/2021
GPNX
NOTIFICATION PROCESSED BY IB
12/06/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/17/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/17/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/17/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/02/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/14/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/14/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/14/2021
RFNT
REFUSAL PROCESSED BY IB
05/30/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/08/2021
RFRR
REFUSAL PROCESSED BY MPU
05/05/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/05/2021
CNRT
NON-FINAL ACTION WRITTEN
05/04/2021
DOCK
ASSIGNED TO EXAMINER
04/24/2021
MAFR
APPLICATION FILING RECEIPT MAILED
01/19/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/15/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/14/2021
Continuous trademark protection
Get notified about every new filing that threatens XPHELYUM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.